U.S. Cosmetic Surgery Market Size, Share, Analysis, By Procedure (Surgical Procedures and Non-Surgical Procedures), By Gender (Female and Male), By Provider (Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers), and Country Forecast, 2024-2032

The U.S. cosmetic surgery market size was worth USD 16.73 billion in 2023 and is projected to grow at a CAGR of 4.3% during the forecast period. 

Cosmetic surgery is considered a voluntary procedure performed for body contouring, body reshaping, and enhancement of an individual's physical appearance. In the past decade, the adoption of cosmetic surgeries, especially minimally invasive and non-invasive procedures, has significantly increased.

• For instance, as per the report published by the American Society of Plastic Surgeons, in 2020, 3.4 million soft tissue filler procedures were performed in the country.

With this growing popularity, the market players have shifted their focus on the development of innovative, and technologically advanced products, such as non-invasive body contouring systems to capture the untapped avenues of the market.

The COVID-19 pandemic negatively affected the market due to the cancellation or postponement of elective and non-essential surgeries in the country. However, with the relaxation of lockdown restrictions, the market regained its pace in 2021 and returned to pre-pandemic growth in 2022.

LATEST TRENDS

Increasing Focus on Aesthetic Appearance

In recent years, cosmetic surgery products have witnessed an exponential increase in demand as aesthetics have become an important aspect of daily life.  The rise in population focusing on aesthetic features has generated promising prospects for the growth of the cosmetic procedure market.

Women’s inclination toward cosmetic procedures, such as breast augmentation, eyelid surgery, liposuction, abdominoplasty, breast lift, and others, for enhanced appearance is increasing, leading to high demand. In addition, the preference is shifting toward non-surgical procedures such as botulinum toxin, hair removal, and others. To capture this opportunity, major players have adopted new and advanced promotional activities, such as campaigns, in order to increase the adoption of botulinum toxin in the country.

• For instance, in January 2019, Allergan plc (AbbVie Inc.) launched its direct-to-customer campaign, “Own Your Look”. The campaign was started to clear out the misconceptions around BOTOX injections (onabotulinumtoxinA). The campaign was created with the aim of inspiring individuals to own their looks and affirm their aesthetic choices.

According to the International Society of Aesthetic Plastic Surgery (ISAPS) data published in 2022, the total number of cosmetic procedures performed in the U.S. was around 7.4 million.

DRIVING FACTORS

Growing Prevalence of Dermatology Conditions in the U.S. to Propel Market Growth

In the U.S., the prevalence of dermatology conditions such as acne, skin cancer, psoriasis, and others is rising among the general population. The presence of a large patient pool with these skin conditions requiring treatment is increasing the need for and demand for advanced cosmetic products in the market. For instance, according to the data published by the Aesthetic Society in 2021, around 1.4 million skin treatment procedures, such as chemical peels, hydro facials, and others, were performed in the U.S.

Furthermore, the population preferring pain-free, and easy methods of appearing youthful and healthy without the problems of invasive cosmetic surgery is also increasing. For example, according to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2020, 1.5 million botulinum toxin procedures were performed in the U.S. Thus, the confluence of the above-mentioned factors is anticipated to fuel market growth.

RESTRAINING FACTORS

High Cost of Cosmetic Surgery Procedures May Impede Growth Prospects 

One of the key factors restraining the U.S. cosmetic surgery market growth includes the high cost of cosmetic surgical procedures in the country. Companies are investing in research and development for the introduction of innovative products. Hence, the cost of products used in cosmetic procedures is too high.

For example, according to the data published by the Aesthetic Society in 2021, it was reported that the average surgeon fee for an abdominoplasty procedure was around USD 6,764. The breast augmentation procedure costs around USD 4,235 in the U.S.

In addition, the huge costs of surgeon fees for various cosmetic procedures such as liposuction, breast augmentation, and others, as well as laser-based treatments for hair removal, skin resurfacing, and others, further limit market growth.

SEGMENTATION

By Procedure Analysis

By procedure, the market is bifurcated into surgical procedures and non-surgical procedures.

The surgical procedures segment held the largest U.S. cosmetic surgery market share in 2022. The segment is further categorized into breast augmentation, eyelid surgery, liposuction, abdominoplasty, rhinoplasty, and others. The increasing patient population undergoing various cosmetic surgery procedures is increasing the demand for such procedures in the country. This, along with the key industry players focusing on new product launches and approvals for these procedures, is fueling segment growth.

• For instance, according to the data published by the Aesthetic Society in 2021, in the U.S., around 2.3 million surgical procedures were performed in 2021 compared to the previous year, in which around 491,098 liposuction procedures were performed.

Whereas, the non-surgical procedures segment is anticipated to witness the fastest growth over the forecast period. The growing demand for non-surgical procedures and the increase in the number of procedures performed, such as botulinum toxin, hair removal, nonsurgical fat reduction, and others, is driving the segment's growth.

By Gender Analysis

Based on gender, the market is bifurcated into female and male.

The female segment secured the largest share of the market in 2022. An increasing number of females undergoing cosmetic procedures such as tummy tuck and breast lifts, along with the growing popularity of minimally invasive procedures such as dermal fillers, botulinum toxin, and others, is fueling the segment growth.

The male segment is anticipated to witness substantial growth over the forecast period. The inclination and rising demand by men for cosmetic procedures such as nose reshaping, eyelid surgery, cheek implants, ear surgery, gynecomastia, and others are responsible for the growth of this segment.

By Provider Analysis

Based on provider, the market is segmented into spas & cosmetic surgery centers and hospitals & specialty clinics.

In 2022, the hospitals & specialty clinics segment held the leading share of the U.S. market. Factors contributing to the dominance of the segment include the high number of cosmetic procedures being performed in these facilities. In addition, specialty clinics have witnessed increasing patient flow in recent years, in turn, driving segment growth.

The spas & cosmetic surgery centers segment is estimated to grow considerably during the forecast period. The growing number of medical spas and cosmetic surgery centers in the country is expected to boost segment growth.

KEY INDUSTRY PLAYERS

The competitive marketspace for the U.S. cosmetic surgery market shows a consolidated structure. Prominent entities such as Johnson & Johnson Services, Inc. (MENTOR), Bausch Health Companies Inc., and AbbVie Inc. lead the U.S. market with a notable share. A strong focus on the launch of technologically advanced products coupled with a wide portfolio of these companies are some of the factors contributing to their market dominance.

• For instance, in January 2021, Allergan Aesthetics, an AbbVie company, introduced CoolSculpting Elite for the treatment of fat bulges in nine areas of the body.

Some other key players that are operational in the market include Merz Pharma, Galderma, Cynosure, and others. These companies are focusing on expanding their product portfolio to enhance their market presence.

LIST OF KEY COMPANIES PROFILED:

• Bausch Health Companies Inc. (Canada)


• Johnson & Johnson Services, Inc. (MENTOR) (U.S.)


• AbbVie Inc. (U.S.)


• Cutera (U.S.)


• Merz Pharma (Germany)


• GALDERMA (Switzerland)


• Sientra, Inc. (U.S.)


• Cynosure (U.S.)


• Apyx Medical (U.S.)


• New York Plastic Surgical Group, PC (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• April 2023: Apyx Medical Corporation received 510(k) clearance from the U.S. FDA to use Renuvion to coagulate subcutaneous soft tissues post liposuction in aesthetic body contouring.


• June 2022: Elite iQ platform was launched by Cynosure in the U.S., Europe, and Australia. This product is used for laser hair removal and skin revitalization.


• January 2021: MENTOR MemoryGel BOOST Breast Implant manufactured by Mentor Worldwide LLC, received approval from the U.S. FDA. This product is used in breast augmentation procedures.

REPORT COVERAGE

The market research report provides a detailed analysis of the market. It focuses on key market segments such as procedures, gender, and provider. In addition, it includes detailed insights on market dynamics, new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. The report also provides the competitive landscape of the key companies at the U.S. level.

Report Scope & Segmentation